Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease

Journal of Zhejiang University: Science B

Volumn 16, Issue 5, 2015, Pages 362-369

  Yang, Zhen kun ^a   Ying, Chen ^a   Zhao, Hong yan ^a   Fang, Yue hua ^a   Chen, Ying ^a   Shen, Wei feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aortic stenosis; Calcium; Mineral metabolism; Phosphate; Valve heart disease

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PROCOLLAGEN; 25-HYDROXYVITAMIN D; AORTIC VALVE DISEASE 1; VITAMIN D;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AORTA ATHEROSCLEROSIS; AORTA VALVE; AORTA VALVE DISEASE; AORTA VALVE STENOSIS; ARTICLE; BONE TURNOVER; CALCIFIC AORTIC VALVE DISEASE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MILD RENAL IMPAIRMENT; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PEAK EXPIRATORY FLOW; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRESSURE GRADIENT; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; BONE; CALCINOSIS; CONGENITAL HEART MALFORMATION; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; HEMODYNAMICS; KIDNEY FAILURE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; VALVULAR HEART DISEASE;

AGED; ALKALINE PHOSPHATASE; AORTIC VALVE; BLOOD PRESSURE; BONE AND BONES; CALCINOSIS; CALCIUM; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATES; REGRESSION ANALYSIS; RENAL INSUFFICIENCY; VITAMIN D;

EID: 84929152928     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1400292     Document Type: Article

References (26)

1. ADA (American Diabetes Association), 2010. Standards of medical care in diabetes 2010. Diabetes Care, 33(Suppl. 1): S11–S61. [doi:10.2337/dc10-S011]
2. Akat, K., Borggrefe, M., Kaden, J.J., 2009. Aortic valve calcification: basic science to clinical practice. Heart, 95(8): 616–623. [doi:10.1136/hrt.2007.134783]
3. Akat, K., Kaden, J.J., Schmitz, F., et al., 2010. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. Am. J. Cardiol., 105(6):862–864. [doi:10.1016/j.amjcard.2009.10.065]
4. Aksoy, O., Cam, A., Goel, S.S., et al., 2012. Do bisphosphonates slow the progression of aortic stenosis? J. Am. Coll. Cardiol., 59(16):1452–1459. [doi:10.1016/j.jacc.2012.01.024]
5. Aksoy, Y., Yagmur, C., Tekin, G.O., et al., 2005. Aortic valve calcification: association with bone mineral density and cardiovascular risk factors. Coron. Artery Dis., 16(6): 379–383. [doi:10.1097/00019501-200509000-00007]
6. Freeman, R.V., Otto, C.M., 2005. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation, 111(24):3316–3326. [doi:10.1161/CIRCULATIONAHA.104.486738]
7. Hekimian, G., Boutten, A., Flamant, M., et al., 2013. Progression of aortic valve stenosis is associated with bone remodeling and secondary hyperparathyroidism in elderly patients—the COFRASA study. Eur. Heart J., 34(25): 1915–1922. [doi:10.1093/eurheartj/ehs450]
8. Innasimuthu, A.L., Katz, W.E., 2011. Effect of bisphosphonates on the progression of degenerative aortic stenosis. Echocardiography, 28(1):1–7. [doi:10.1111/j.1540-8175.2010.01256.x]
9. Iung, B., Baron, G., Butchart, E.G., et al., 2003. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur. Heart J., 24(13):1231–1243. [doi:10.1016/S0195-668X(03)00201-X]
10. Iwata, S., Hyodo, E., Yanagi, S., et al., 2013. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int. J. Cardiol., 163(3):256–259. [doi:10.1016/j.ijcard.2011.06.025]
11. Kume, T., Kawamoto, T., Akasaka, T., et al., 2006. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J. Am. Soc. Echocardiogr., 19(7):914–918. [doi:10.1016/j.echo.2006.01.026]
12. Linefsky, J.P., O'Brien, K.D., Katz, R., et al., 2011. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the Cardiovascular Health Study. J. Am. Coll. Cardiol., 58(3):291–297. [doi:10.1016/j.jacc.2010.11.073]
13. Linhartová, K., Veselka, J., Sterbáková, G., et al., 2008. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ. J., 72(2): 245–250. [doi:10.1253/circj.72.245]
14. Mills, W.R., Einstadter, D., Finkelhor, R.S., 2004. Relation of calcium-phosphorus production to the severity of aortic stenosis in patients with normal renal function. Am. J. Cardiol., 94(9):1196–1198. [doi:10.1016/j.amjcard.2004.07.095]
15. Nagy, E., Eriksson, P., Yousry, M., et al., 2013. Valvular osteoclasts in calcification and aortic valve stenosis severity. Int. J. Cardiol., 168(3):2264–2271. [doi:10.1016/j.ijcard.2013.01.207]
16. O'Neill, W.C., 2007. The fallacy of the calcium-phosphorus product. Kidney Int., 72(7):792–796. [doi:10.1038/sj.ki.5002412]
17. Parolari, A., Loardi, C., Mussoni, L., et al., 2009. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur. J. Cardiothorac. Surg., 35(3):493–504. [doi:10.1016/j.ejcts.2008.11.033]
18. Parolari, A., Tremoli, E., Cavallotti, L., et al., 2011. Do statins improve outcomes and delay the progression of nonrheumatic calcific aortic stenosis? Heart, 97(7):523–529. [doi:10.1136/hrt.2010.215046]
19. Rajamannan, N.M., 2009. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler. Thromb. Vasc. Biol., 29(2):162–168. [doi:10.1161/ATVBAHA.107.156752]
20. Rajamannan, N.M., Evans, F.J., Aikawa, E., et al., 2011. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Circulation, 124(16):1783–1791. [doi:10.1161/CIRCULATIONAHA.110.006767]
21. Skolnick, A.H., Osranek, M., Formica, P., et al., 2009. Osteoporosis treatment and progression of aortic stenosis. Am. J. Cardiol., 104(1):122–124. [doi:10.1016/j.amjcard.2009.02.051]
22. Stefenelli, T., Mayr, H., Bergler-Klein, J., et al., 1993. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med., 95(2):197–202. [doi:10.1016/0002-9343(93)90260-V]
23. Sterbakova, G., Vyskocil, V., Linhartova, K., 2010. Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease—a pilot retrospective study. Cardiology, 117(3):184–189. [doi:10.1159/000321418]
24. Strickberger, S.A., Schulman, S.P., Hutchins, G.M., 1987. Association of Paget’s disease of bone with calcific aortic valve disease. Am. J. Med., 82(5):953–956. [doi:10.1016/0002-9343(87)90157-4]
25. Teo, K.K., Corsi, D.J., Tam, J.W., et al., 2011. Lipid lowering on progression of mild to moderate aortic stenosis: metaanalysis of the randomized placebo-controlled clinical trials on 2344 patients. Can. J. Cardiol., 27(6):800–808. [doi:10.1016/j.cjca.2011.03.012]
26. Yetkin, E., Waltenberger, J., 2009. Molecular and cellular mechanisms of aortic stenosis. Int. J. Cardiol., 135(1): 4–13. [doi:10.1016/j.ijcard.2009.03.108]